Target group
The funding program is aimed at researchers working in the field of personalized medicine at universities, non-academic research institutions, and research departments in related sectors.
Funding goals
EP PerMed aims to improve health outcomes within sustainable healthcare systems through research and the development, innovation, and implementation of personalized medicine approaches for the benefit of patients, citizens, and society.
Funding period and funding amount
Up to 36 months, max. € 450,000
Requirements
The requirements and specifications for the FWF programs Principal Investigator Projects or Clinical Research apply.
Information on the current call “Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)”
With this Joint Transnational Call, EP PerMed will fund research projects in human health on innovative PM strategies for patients with cardiovascular, metabolic or kidney diseases. Research projects may focus on a single disease or explore these conditions in combination.
Proposals should address one or more of the following aspects:
- Development and validation of innovative personalised therapeutic approaches for cardiovascular, metabolic or kidney diseases through testing in relevant pre-clinical models (e.g., human cell cultures, organoids, organs-on-chips, disease-specific animal models, or in silico models)
- Identification and validation of molecular markers/signatures or cutting-edge technologies (see also point 2 below) to monitor treatment response in patients with cardiovascular, metabolic or kidney diseases in order to tailor treatment pathways. This may include the analysis of the treatment effectiveness or treatment-related (including multi-medication) adverse effects as well as dose optimisation.
- Identification and validation of stratifying molecular markers/signatures or stratifying diagnostic technologies for early disease risk prediction and prevention of disease worsening or comorbidities in patients with cardiovascular, metabolic or kidney diseases, thereby delaying the progression to cardiovascular-kidney-metabolic syndrome
For further information on the topics and requirements of this call, please see the CARMEN 2026 website.
Each application must be supported by a minimum of three and a maximum of six partners from at least three participating partner countries, whereby a joint document must be submitted to the central Call Secretariat by the coordinator.
The researchers are funded by their respective national/regional funding organization.
Funding organizations from 27 countries are planning to join this call. Please see the CARMEN2026 website for the current list of participating countries.
Approval
Decided by the Scientific Board based on a recommendation of the Call Secretariat
Application information
Applications are submitted online by February 10, 2026, using the Call Secretariat’s system. Please see the CARMEN2026 website for a link to the application submission system.
There will be a two-step submission and review procedure.
- Deadline for pre-proposal submission: February 10, 2026 (2:00 pm CET)
- Deadline for full proposal submission: June 9, 2026 (2:00 pm CEST)
- Funding decision: expected in October 2026
In addition to the application submitted to the Call Secretariat, administrative and financial data as well as academic abstracts (in accordance with the FWF guidelines for Principal Investigator Projects or Clinical Research) must also be submitted to the FWF using the online portal elane. In the pre-proposal stage, proposals are submitted under the program category “PIK – International Projects – pre-proposal” (deadline February 11, 2026, 2:00 pm Vienna local time). For the full proposal stage, applicants must choose the program category “KIN – International – Multilateral Initiatives” (deadline June 10, 2026, 2:00 pm Vienna local time).
Please note that the research institution must approve the proposal for submission by the deadlines indicated above. To do so, research institutions must be registered on the FWF research institution portal.
Both steps are mandatory.
Funding institution
Austrian Science Fund (FWF)
Further information
- The maximum amount that can be requested for Austrian project partners is € 450,000.
- For general questions about the call, please contact the Joint Call Secretariat (JCS) at EPPerMed(at)agencerecherche.fr. For specific questions related to the budget, criteria, and rules of your funding organization, please consult your funding organization directly. Contacts and details of the national and regional regulations of the individual funding organizations can be found in the call text on the CARMEN2026 website.